Bayesian Capital Management, LP Cytokinetics Inc Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $76,576 - $120,080	1,600 Added 5.22%	32,274 $1.75 Million
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $510,000 - $864,480	-8,000 Reduced 20.69%	30,674 $2.15 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $1.04 Million - $3.23 Million	38,674 New	38,674 $3.23 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $197,624 - $270,786	5,924 Added 64.39%	15,124 $532,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $329,084 - $470,212	9,200 New	9,200 $421,000
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $200,187 - $288,628	5,900 New	5,900 $232,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.